A Study to Evaluate the Mass Balance of [14C]SHR7280 in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 7, 2024

Primary Completion Date

July 6, 2024

Study Completion Date

July 6, 2024

Conditions

Assisted Reproduction

Interventions

DRUG

[14C]SHR7280

Patients will receive single dose of orally \[14C\]SHR7280 on Day 1.

Trial Locations (1)

The First Affiliated Hospital of Suzhou University, Suzhou

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT06408948 - A Study to Evaluate the Mass Balance of [14C]SHR7280 in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter